Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review)
- Authors:
- Mahdi Hussain Al Bandar
- Nam Kyu Kim
-
Affiliations: Department of Surgery, Yonsei University, College of Medicine, Seoul 120-752, Republic of Korea - Published online on: March 27, 2017 https://doi.org/10.3892/or.2017.5531
- Pages: 2553-2564
This article is mentioned in:
Abstract
 |
 |
|
Lykoudis PM, O'Reilly D, Nastos K and Fusai G: Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 101:605–612. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, Sobrero A and Ychou M: European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop: Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel. Ann Oncol. 20:985–992. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ and Rees M: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer. 94:982–999. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
van Dijk TH, Tamas K, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de Velde CJ, Wiggers T, et al: Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol. 24:1762–1769. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J and Bouvier AM: Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 244:254–259. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bozzetti F, Doci R, Bignami P, Morabito A and Gennari L: Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 205:264–270. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Konopke R, Roth J, Volk A, Pistorius S, Folprecht G, Zöphel K, Schuetze C, Laniado M, Saeger HD and Kersting S: Colorectal liver metastases: An update on palliative treatment options. J Gastrointestin Liver Dis. 21:83–91. 2012.PubMed/NCBI | |
|
Cummings LC, Payes JD and Cooper GS: Survival after hepatic resection in metastatic colorectal cancer: A population-based study. Cancer. 109:718–726. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L and Pawlik TM: Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients. Ann Surg. 250:440–448. 2009.PubMed/NCBI | |
|
Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, et al: Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 23:2619–2626. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Mekenkamp LJ, Koopman M, Teerenstra S, van Krieken JH, Mol L, Nagtegaal ID and Punt CJ: Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs. metachronous metastases. Br J Cancer. 103:159–164. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Siriwardena AK, Mason JM, Mullamitha S, Hancock HC and Jegatheeswaran S: Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol. 11:446–459. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Adam R: Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol. 14:(Suppl 2). ii13–ii16. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Nordlinger B, Van Cutsem E, Rougier P, Köhne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, et al: Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 43:2037–2045. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, et al: EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD): Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet. 371:1007–1016. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 351:337–345. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Bramhall SR, Gur U, Coldham C, Gunson BK, Mayer AD, McMaster P, Candinas D, Buckels JA and Mirza DF: Liver resection for colorectal metastases. Ann R Coll Surg Engl. 85:334–339. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Clavien PA, Petrowsky H, DeOliveira ML and Graf R: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 356:1545–1559. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hou W and Zhu X: Extra vascular interventional treatment of liver cancer, present and future. Drug Discov Ther. 9:335–341. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
van Dam RM, Lodewick TM, van den Broek MA, de Jong MC, Greve JW, Jansen RL, Bemelmans MH, Neumann UP, Damink Olde SW and Dejong CH: Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases. HPB (Oxford). 16:550–559. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, Kennamer DL, Ellis LM and Curley SA: Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 239:722–730; discussion 730–732. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tsoulfas G, Pramateftakis MG and Kanellos I: Surgical treatment of hepatic metastases from colorectal cancer. World J Gastrointest Oncol. 3:1–9. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN and Curley SA: Debunking dogma: Surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 10:240–248. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Altendorf-Hofmann A and Scheele J: A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am. 12:165–192, xi. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Pulitanò C, Bodingbauer M, Aldrighetti L, de Jong MC, Castillo F, Schulick RD, Parks RW, Choti MA, Wigmore SJ, Gruenberger T, et al: Liver resection for colorectal metastases in presence of extrahepatic disease: Results from an international multi-institutional analysis. Ann Surg Oncol. 18:1380–1388. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mattar RE, Al-Alem F, Simoneau E and Hassanain M: Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol. 22:567–581. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Abdalla EK, Denys A, Chevalier P, Nemr RA and Vauthey JN: Total and segmental liver volume variations: Implications for liver surgery. Surgery. 135:404–410. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chang GJ: Challenge of primary tumor management in patients with stage IV colorectal cancer. J Clin Oncol. 30:3165–3166. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ and Cameron JL: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 235:759–766. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg. 230:309–318; discussion 318–321. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Kemeny N, Kemeny MM and Lawrence TS: Liver metastasesClinical Oncology. Abeloff MD, Armitage JO, Lichter AS and Niederhuber JE: Churchill Livingstone; New York: pp. 886–921. 2000 | |
|
National Comprehensive Cancer Network: Colon cancer guidelines version 3. 2012.(28/9/2014). http://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf | |
|
Bai H, Huangz X, Jing L, Zeng Q and Han L: The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): A meta-analysis. Hepatogastroenterology. 62:373–377. 2015.PubMed/NCBI | |
|
Gruenberger Th, Gruenberger B, Becherer A, Kettenbach J, Dieckmann K and Schima W: Interdisciplinary management of colorectal cancer liver metastases. Eur Surg. 38:107–111. 2006. View Article : Google Scholar | |
|
Viganò L, Capussotti L, De Rosa G, De Saussure WO, Mentha G and Rubbia-Brandt L: Liver resection for colorectal metastases after chemotherapy: Impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg. 258:731–742. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F and Bismuth H: Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg. 240:1052–1064. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gruenberger B, Scheithauer W, Punzengruber R, Zielinski C, Tamandl D and Gruenberger T: Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer. 8:1202008. View Article : Google Scholar : PubMed/NCBI | |
|
Khan AZ, Morris-Stiff G and Makuuchi M: Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg. 16:137–144. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D and Adam R: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 24:4983–4990. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pulitanò C, Aldrighetti L, Arru M, Vitali G, Ronzoni M, Catena M, Finazzi R, Villa E and Ferla G: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 244:833–835; author reply 835. 2006. View Article : Google Scholar | |
|
Khoo E, O'Neill S, Brown E, Wigmore SJ and Harrison EM: Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases. HPB (Oxford). 18:485–493. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Primrose J, Falk S, Finch-Jones M, Valle J, O'Reilly D, Siriwardena A, Hornbuckle J, Peterson M, Rees M, Iveson T, et al: Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: The New EPOC randomised controlled trial. Lancet Oncol. 15:601–611. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fujita S, Akasu T and Moriya Y: Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol. 30:7–11. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H and Togo S: Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 136:650–659. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, Jarnagin W and Blumgart L: Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 197:233–241; discussion 241. –242. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG and Nagorney DM: Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum. 47:1310–1316. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Silberhumer GR, Paty PB, Denton B, Guillem J, Gonen M, Araujo RL, Nash GM, Temple LK, Allen PJ, DeMatteo RP, et al: Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. Surgery. 160:67–73. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jaeck D and Pessaux P: Bilobar colorectal liver metastases: Treatment options. Surg Oncol Clin N Am. 17:553–568, ix. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma S, Camci C and Jabbour N: Management of hepatic metastasis from colorectal cancers: An update. J Hepatobiliary Pancreat Surg. 15:570–580. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM and Nagorney DM: Hepatic resection for colorectal metastases: Value for risk scoring systems? Ann Surg. 246:183–191. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Leonard GD, Brenner B and Kemeny NE: Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 23:2038–2048. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Scheithauer W, Rosen H, Kornek GV, Sebesta C and Depisch D: Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. 306:752–755. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, et al: Irinotecan Study Group: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 343:905–914. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 18:2938–2947. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, Artale S, Tagliagambe A, Ambrosini G, Rosetti P, et al: Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol. 29:2773–2780. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab HR, et al: German Rectal Cancer Study Group: Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 13:679–687. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Allegra CJ, Yothers G, O'Connell MJ, Beart RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A, et al: Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: A phase III randomized clinical trial. J Natl Cancer Inst. 107:pii: djv248. 2015. View Article : Google Scholar : | |
|
Schmoll H-J, Haustermans K, Price TJ, Nordlinger B, Hofheinz R, Daisne J-F, Janssens J, Brenner B, Schmidt P, Reinel H, et al: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial. J Clin Oncol. 31:(Suppl). 35312013.PubMed/NCBI | |
|
Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, François E, de La Roche G, Bouché O, et al: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol. 28:1638–1644. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
An X, Lin X, Wang FH, Goodman K, Cai PQ, Kong LH, Fang YJ, Gao YH, Lin JZ, Wan DS, et al: Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: A meta analysis. Eur J Cancer. 49:843–851. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Razafindratsira T, Isambert M and Evrard S: Complications of intraoperative radiofrequency ablation of liver metastases. HPB (Oxford). 13:15–23. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Evrard S, Rivoire M, Arnaud J, Lermite E, Bellera C, Fonck M, Becouarn Y, Lalet C, Puildo M and Mathoulin-Pelissier S: Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg. 99:558–565. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol. 22:229–237. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, et al: Gruppo Oncologico Nord Ovest: Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: The Gruppo Oncologico Nord Ovest. J Clin Oncol. 25:1670–1676. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, et al: Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol. 26:2013–2019. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, Donea S, Ludwig H, Schuch G, Stroh C, et al: Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol. 27:663–671. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kim KH, Shin SJ, Cho MS, Ahn JB, Jung M, Kim TI, Park YS, Kim H, Kim NK and Koom WS: A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis. Radiother Oncol. 118:369–374. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Grothey A, Jordan K, Kellner O, Constantin C, Dietrich G, Kroening H, Mantovani L, Schlichting C, Forstbauer H and Schmoll H-J: Capecitabine/irinotecan (Capiri) and capecitabine/oxaliplatin (CapOx) are active second-line protocols in patients with advanced colorectal cancer (ACRC) after failure of first-line combination therapy: results of a randomized phase II study. J Clin Oncol. 22:(Suppl 14). 35342004. View Article : Google Scholar | |
|
Shimonov M, Hayat H, Chaitchik S, Brener J, Schachter P and Czerniak A: Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver. Chemotherapy. 51:111–115. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kelly RJ, Kemeny NE and Leonard GD: Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer. 5:166–174. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lévi F, Giacchetti S, Adam R, Zidani R, Metzger G and Misset JL: Chronomodulation of chemotherapy against metastatic colorectal cancer. Eur J Cancer. 31A:1264–1270. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Shin SJ, Yoon HI, Kim NK, Lee KY, Min BS, Ahn JB, Keum KC and Koom WS: Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol. 6:992011. View Article : Google Scholar : PubMed/NCBI | |
|
Radu C, Berglund A, Påhlman L and Glimelius B: Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. Radiother Oncol. 87:343–349. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon HI, Koom WS, Kim TH, Ahn JB, Jung M, Kim TI, Kim H, Shin SJ and Kim NK: Upfront systemic chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases: Outcomes, compliance, and favorable prognostic factors. PLoS One. 11:e01614752016. View Article : Google Scholar : PubMed/NCBI | |
|
Brooks AJ, Wang F, Alfredson M, Yan TD and Morris DL: Synchronous liver resection and cryotherapy for colorectal metastases: survival analysis. Surgeon. 3:265–268. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kennedy JE, Wu F, ter Haar GR, Gleeson FV, Phillips RR, Middleton MR and Cranston D: High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 42:931–935. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K and Curley SA: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 239:818–827. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Khatri VP, Chee KG and Petrelli NJ: Modern multimodality approach to hepatic colorectal metastases: Solutions and controversies. Surg Oncol. 16:71–83. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu J, Chen S and Wu H: Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies. J Surg Res. 188:14–20. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Park MJ, Kim TH, Lee KM, Cheong JY and Kim JK: Radiofrequency ablation of metastatic liver masses: Recurrence patterns and prognostic factors based on radiologic features. Hepatogastroenterology. 60:563–567. 2013.PubMed/NCBI | |
|
Hur H, Ko YT, Min BS, Kim KS, Choi JS, Sohn SK, Cho CH, Ko HK, Lee JT and Kim NK: Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg. 197:728–736. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Mima K, Beppu T, Chikamoto A, Miyamoto Y, Nakagawa S, Kuroki H, Okabe H, Hayashi H, Sakamoto Y, Watanabe M, et al: Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol. 18:847–855. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Berber E, Pelley R and Siperstein AE: Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: A prospective study. J Clin Oncol. 23:1358–1364. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF and Gazelle GS: Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology. 221:159–166. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Mulier S, Ni Y, Jamart J, Ruers T, Marchal G and Michel L: Local recurrence after hepatic radiofrequency coagulation: Multivariate meta-analysis and review of contributing factors. Ann Surg. 242:158–171. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G and Abraha I: Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 6:CD0063172012. | |
|
Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH and Stoker J: Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology. 237:123–131. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Elias D, De Baere T, Roche A, Mducreux Leclere J and Lasser P: During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 86:784–788. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Denys A, Bize P, Demartines N, Deschamps F and De Baere T: Cardiovascular and Interventional Radiological Society of Europe: Quality improvement for portal vein embolization. Cardiovasc Intervent Radiol. 33:452–456. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Abdalla EK, Bauer TW, Chun YS, D'Angelica M, Kooby DA and Jarnagin WR: Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford). 15:119–130. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, et al: High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome. J Clin Oncol. 29:1083–1090. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, Marzano E and Bachellier P: Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 98:1463–1475. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Simoneau E, Aljiffry M, Salman A, Abualhassan N, Cabrera T, Valenti D, El Baage A, Jamal M, Kavan P, Al-Abbad S, et al: Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford). 14:461–468. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Maggiori L, Bretagnol F, Sibert A, Paradis V, Vilgrain V and Panis Y: Selective portal vein ligation and embolization induce different tumoral responses in the rat liver. Surgery. 149:496–503. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A and Davidson BR: Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer. 100:617–622. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zou RH, Li AH, Han F, Hong J, Li BK, Huang W, Huang L and Yuan YF: Liver hypertrophy and accelerated growth of implanted tumors in nonembolized liver of rabbit after left portal vein embolization. J Surg Res. 178:255–263. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, van Het Schip AD and Nijsen JF: Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: A structured meta-analysis. Eur Radiol. 19:951–959. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
de Graaf W, van den Esschert JW, van Lienden KP and van Gulik TM: Induction of tumor growth after preoperative portal vein embolization: Is it a real problem? Ann Surg Oncol. 16:423–430. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, et al: Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 255:405–414. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gauzolino R, Castagnet M, Blanleuil ML and Richer JP: The ALPPS technique for bilateral colorectal metastases: Three ‘variations on a theme’. Updates Surg. 65:141–148. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Honjo I, Suzuki T, Ozawa K, Takasan H, Kitamura O and Ishikawa T: Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg. 130:296–302. 1975. View Article : Google Scholar : PubMed/NCBI | |
|
Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V and Belghiti J: Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg. 12:297–303. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Robles R, Marín C, Lopez-Conesa A, Capel A, Perez-Flores D and Parrilla P: Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases. Eur J Surg Oncol. 38:586–593. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, Abdalla EK, Hernandez-Alejandro R, Jovine E, Machado M, et al: Prediction of mortality after ALPPS Stage-1: An analysis of 320 patients from the International ALPPS Registry. Ann Surg. 262:780–786. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ and Aloia TA: Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 217:126–134. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A and Lodge JP: A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery. 157:690–698. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Z, Tang W, Sakamoto Y, Hasegawa K and Kokudo N: A systematic review and meta-analysis of feasibility, safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH). Biosci Trends. 9:284–288. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shteyer E, Liao Y, Muglia LJ, Hruz PW and Rudnick DA: Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology. 40:1322–1332. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B and van Gulik TM: Physiological and biochemical basis of clinical liver function tests: A review. Ann Surg. 257:27–36. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Guiu B, Bize P, Gunthern D, Demartines N, Halkic N and Denys A: Portal vein embolization before right hepatectomy: Improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol. 36:1306–1312. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Eshmuminov D, Raptis DA, Linecker M, Wirsching A, Lesurtel M and Clavien PA: Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br J Surg. 103:1768–1782. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ and Li AK: Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys. 40:583–592. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, et al: Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol. 16:937–945. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Welsh JS, Kennedy AS and Thomadsen B: Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys. 66:(Suppl). S62–S73. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G and Gray B: Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 88:78–85. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, Perez D, Robinson BA, Strickland AH, Ferguson T, et al: SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol. 34:1723–1731. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bokemeyer C, Van Cutsem E, Rougier P, Ciardiello F, Heeger S, Schlichting M, Celik I and Köhne CH: Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials. Eur J Cancer. 48:1466–1475. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D, Bower G, Shannon JA, Gibbs P and Steward WP: Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol. 25:1099–1106. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Stubbs RS and Wickremesekera SK: Selective internal radiation therapy (SIRT): A new modality for treating patients with colorectal liver metastases. HPB (Oxford). 6:133–139. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, et al: EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD): Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 14:1208–1215. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Choi Kwok-Keung C and Santoro A: A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol. 20:1964–1970. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, et al: Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 24:4976–4982. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hatfield P, Hingorani M, Radhakrishna G, Cooper R, Melcher A, Crellin A, Kwok-Williams M and Sebag-Montefiore D: Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol. 92:210–214. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B and Martling A: Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg. 99:577–583. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Turkmen C, Ucar A, Poyanli A, Vatankulu B, Ozkan G, Basaran M, Serin K, Sanli Y and Adalet I: Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease. Cancer Biother Radiopharm. 28:534–540. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kucuk ON, Soydal C, Lacin S, Ozkan E and Bilgic S: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World J Surg Oncol. 9:862011. View Article : Google Scholar : PubMed/NCBI | |
|
Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B and Sandström P: Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases - Intermediate oncological results. Eur J Surg Oncol. 42:531–537. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kremer M, Manzini G, Hristov B, Polychronidis G, Mokry T, Sommer CM, Mehrabi A, Weitz J, Büchler MW and Schemmer P: Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy. J Am Coll Surg. 221:717–728.e1. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Torres OJ, Fernandes ES, Oliveira CV, Lima CX, Waechter FL, Moraes-Junior JM, Linhares MM, Pinto RD, Herman P and Machado MA: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): The Brazilian experience. Arq Bras Cir Dig. 26:40–43. 2013. View Article : Google Scholar : PubMed/NCBI |
